Home Exercises for Fall-related Variables in Elderly Adults

April 14, 2022 updated by: Taciser Kaya, Bozyaka Training and Research Hospital

Effects of Supervised Versus Unsupervised Home Exercises on Fall-related Variables for Community-dwelling Older Adults

The aim was to measure and compare the effects of supervised and unsupervised home exercises on the fall related variables.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

There are several studies investigating the beneficial effects of exercise on physical function among elderly. However the trials that reporting beneficial effects of an exercise programme on psychosocial functions such as depression and falls efficacy are scarcend. And also these trials are designed to compare fully supervised experimental group with a control group receiving usual care. In only one, out of these studies, supervision was minimal and delivered via home visit. However no psychosocial function related outcome measure was evaluated. In the present study the investigators have intended to assess the effects of minimally supervised home exercise programme on physical and psychosocial fall related variables by comparing with unsupervised home exercise programme in community-dwelling older adults.

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Ability to perform timed up and go (TUG) test
  • not having regular exercise habit
  • a score above 20 on the Mini Mental State Examination (MMSE)

Exclusion Criteria:

  • medical conditions impeding to perform exercises such as severe musculoskeletal and neurological disease, severe visual impairment, cardiovascular, pulmonary or malignant disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Community-dwelling older adults receiving supervision
Group I; supervised home exercise group
stretching, balance and strengthening exercises
Active Comparator: Community-dwelling older adults not supervised
Group II; unsupervised home exercise group
stretching, balance and strengthening exercises

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Falls efficacy
Time Frame: baseline, eighth week, sixth month
It was assessed using the Falls Efficacy Scale International (FES-I). FES-I is a self-rating questionnaire designed for measuring concerns about the possibility of falling during several activities of daily living. In total, sixteen practices and activities, which are carried out at home such as cooking, dressing, taking a bath; and out of home such as visiting someone, walking on an uneven surface or shopping are scored between 1 and 4 (1 = not at all concerned, 4 = very concerned). The range of total score varies between 16 to 64 and the higher the score the lower the falls efficacy. The investigators have aimed to measure the change in falls efficacy between three time points (baseline, eighth week, sixth month)in order to explore whether there is an improvement in this outcome measure. The change in falls efficacy was calculated by using suitable nonparametric statistical analysis methods.
baseline, eighth week, sixth month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fear of Falling (FOF)
Time Frame: baseline, eighth week, sixth month
Visual Analog Scale (VAS) was used for measuring FOF subjectively. Participants were asked to indicate the degree of falling fear by making a mark on a 100 milimeter line (zero; not at all, 100; maximum fear). A new paper sheet was used at each visit so that the participants couldn't see the previous response that they have given. This was done with the purpose of prevent them from getting biased.
baseline, eighth week, sixth month
Functional Mobility
Time Frame: baseline, eighth week, sixth month
To assess functional mobility Timed up and go (TUG) test was used. Participants were requested to walk at their ordinary walking speed during TUG test. They were seated at the beginning of the test and asked for rising from chair after the command "ready-set-go", walking 3 meters, turning around, going back to chair and sitting down again. Duration between rising from chair and sitting down was recorded with a stopwatch. Before testing, participants were instructed about testing procedure and one test trial was performed for this purpose.
baseline, eighth week, sixth month
Balance Performance
Time Frame: baseline, eighth week, sixth month
With the aim of rating balance performance, Balance Performance Oriented Mobility Assessment (BPOMA) of Tinetti was used. In this test, eight different tasks are scored between 0-2. Maximum possible score is 16 and higher score is related to the better balance performance. For detailed information; this test evaluates sitting and standing balance, turning 360°, the ability of arising from chair and sitting down.
baseline, eighth week, sixth month
Fall risk
Time Frame: baseline, eighth week, sixth month
Elderly Falls Screening Test (EFST) was used to assess risk of fall. It is composed of two parts, one of which queries fall number in the last year, history of injurious fall and near fall; the second evaluates walking speed and style. The first part is self-report and covers three items; the second part is scored by assessor and covers two items. Maximum possible score is five. A score between 0-1 indicates low, 2-3 moderate and 4-5 high fall risk.
baseline, eighth week, sixth month
Geriatric Depression Scale Short Form (GDS-SF)
Time Frame: baseline, eighth week, sixth month
This scale is used for defining the depressive symptoms. It covers fifteen dichotomous questions that ask participants to answer in a yes or no fashion. Of the 15 questions, 10 indicate the presence of depression when answered as yes while remaining five indicate the presence of depression when answered as no. An answer in the direction of depression is assumed as one point. To get a final score, all points are summed. Thus, total score is between 0-15. A score between 0-5 is normal, a score above 5 suggests depression.
baseline, eighth week, sixth month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Taciser Kaya, Prof., MD, Izmir Bozyaka Training and Reseach Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 20, 2012

Primary Completion (Actual)

July 20, 2013

Study Completion (Actual)

October 20, 2013

Study Registration Dates

First Submitted

April 1, 2022

First Submitted That Met QC Criteria

April 14, 2022

First Posted (Actual)

April 20, 2022

Study Record Updates

Last Update Posted (Actual)

April 20, 2022

Last Update Submitted That Met QC Criteria

April 14, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 21102021TK

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Community-dwelling Older Adults

Clinical Trials on home exercises

Subscribe